摘要
目的探讨临床路径管理引入后对婴儿肥厚性幽门狭窄(HPS)临床结果的影响。方法回顾性分析1992年1月至2014年12月我院临床医学中心收治的HPS病例337例,按照入院时间先后分组,分析各相关因素对临床治疗结果的影响。比较引入临床路径管理前后各3年病例的临床结果。观察指标包括:住院天数、术后达全量喂养时间、术后住院天数、并发症及住院费用等。结果引入临床路径管理前后各3年间病例共134例,其中前3年未引入路径管理58例,后3年引入路径管理76例,两组均采取术后12小时内开始喂养的方案。引入路径管理后,住院天数、术后住院天数减少,差异有统计学意义(P<0.05),术后达全量喂养时间和可比住院费用差异无统计学意义(P>0.05)。结论 HPS早期手术、术后早期喂养及腹腔镜手术的策略可改善临床结果。引人临床路径管理可有利于规范医疗行为,从而影响治疗结果。本研究显示,对HPS引入临床路径管理是值得推荐应用的。
Objective To analyze the effect of clinical pathway management on the clinical outcome of infantile hypertrophic pyloric stenosis （ HPS） .Methods A retrospective analysis of 337 cases of HPS from 1992 to 2014 in our hospital was performed .The patients were grouped according to the time of admission .The effect of relevant factors on the treatment outcome was analyzed .The clini-cal outcomes of introducing the clinical pathway before and after 3 years,total of 6 years,were compared.The clinical parameters includ-ed hospital days ,postoperative feeding time ,postoperative hospital stay ,complications and hospitalization expenses were also compared . Results There were 134 children before and after the introduction of clinical pathway management .In the first 3 years,58 cases were introduced into the path management ,and after 3 years,76 cases were introduced .Two groups were taken oral feeding within 12 hours after the operation .After the introduction of path management ,hospital days and postoperative hospital stay were reduced .The difference was statistically significant （P 〈0.05）.However,there was no significant difference between the feeding time and the hospitalization cost （P〉0.05）.Conclusion Early surgery,early postoperative feeding and laparoscopic surgery can improve the clinical outcome of HPS.The clinical pathway management can be beneficial to regulate medical behavior , so as to influence the treatment results .This study shows that the introduction of clinical pathway into HPS is worthy of recommendation .
出处
《实用医院临床杂志》
2016年第4期8-11,共4页
Practical Journal of Clinical Medicine
关键词
肥厚性幽门狭窄
临床路径
治疗结果
Hypertrophic pyloric stenosis
Clinical pathway
Treatment outcome
